retatrutide diabetes type 1 Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USA ๐จ Today, retatrutide, the GIP/GLP-1/glucagon
Pay in 4 interest-free payments of $5.64 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours ยท Estimated delivery Aug 1 - Aug 6




























